scholarly journals The Frequency of Malnutrition in Patients with Type 2 Diabetes

2021 ◽  
Author(s):  
Miraç Vural Keskinler ◽  
Güneş Feyizoğlu ◽  
Kübra Yıldız ◽  
Aytekin Oğuz
Keyword(s):  
Type 2 Diabetes ◽  
Outpatient Clinic ◽  
High Body Mass Index ◽  
Cross Sectional Study ◽  
University Hospital ◽  
Nutritional Risk ◽  
Cross Sectional ◽  
Significant Difference ◽  
Nrs 2002

Objective: Obesity is one of the most common comorbidities of diabetes mellitus (DM) whose frequency is rapidly increasing nowadays. Although obesity caused by excessive and unbalanced nutrition often accompanies diabetes; malnutrition is another complication of diabetes. This study was conducted to investigate the frequency of malnutrition in individuals with diabetes. Method: This study is a cross-sectional study. The patients with type 2 diabetes followed up in the diabetes outpatient clinic of a university hospital between February and March 2018 were included in the study. Anthropometric measurements of the patients and “Nutritional Risk Screening-2002” (NRS-2002) scores were recorded. Results: A total of 222 (F: 132 59.4%) patients were included in the study. When two groups with higher NRS (≥3) and lower NRS (<3) scores less than 3 were compared, any significant difference was not detected between two groups in terms of age, waist circumference and HbA1c values. Only BMI was found to be lower in the group with malnutrition risk (p: 0.030). When the patients were evaluated in terms of diabetes treatments and risk of malnutrition, any significant intergroup difference was not found (p: 0.847). Conclusion: It was found that there is a risk of malnutrition in one of every seven diabetics with a high body mass index who were being followed up in the diabetes outpatient clinic.

Abstract 660: Prevalence of Hypertension Among Children with Diabetes Mellitus.

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Robert O Drutel ◽  
Remberto Paulo
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Age Groups ◽  
Cross Sectional Study ◽  
University Hospital ◽  
Cross Sectional ◽  
Study Population ◽  
Standard Of Practice ◽  
Age Range

This study aims to determine the prevalence of hypertension among children with diabetes mellitus, and describe adherence to the standard of practice regarding early diagnosis and treatment of hypertension in this population. Diabetes renders higher susceptibility to cardiovascular disease in affected patients and thus early detection of hypertension can be beneficial for future quality of life. We hypothesize that a number of diabetic children with hypertension are not promptly diagnosed and treated due to the difficult process preceding diagnosis. This cross-sectional study in an out-patient clinic of a university hospital was based on a group of 263 children (both females and males, age range between 3-18) diagnosed with type 2 diabetes. At the visit, the child's weight and height were recorded, BMI was calculated, systolic and diastolic blood pressure (BP) was taken, and blood sample drawn for hemoglobin A1C (HbA1C) readings. Within the study population we have identified a group of 73 children with hypertension. Comparing the two groups: the normotensive with the hypertensive, we have observed that the normotensive patients have significantly lower average BMI (26.7), p=0.000012 and slightly reduced HbA1C (8.9%), p=0.28 levels compared to the hypertensive group: BMI (32.5) and HbA1C (9.3%), respectively. We investigated the same parameters within every age group starting from age 10, and recorded that HbA1C was only significantly different for the group of 14 year-olds (8.7%; 11.7%, p=0.039). We also found that a significantly higher BMI is linked with hypertension for groups: age 13: BMI (29.2; 33.9, p=0.047), age 14: BMI (24.1; 35.6, p=0.00007) and age 18: BMI (31.8; 45.6, p=0.045). Within the different age groups there were differences between normotensive and hypertensive patients in BMI and HbA1C measurements, but they were not statistically significant and we assume that an increased sample size would be needed to confirm the data. We are currently working on identifying other risk factors including sex, race, height, urine creatinine, urine microalbumin, serum creatinine, lipid profile and thyroid function, that might be responsible for hypertension in pediatric patients with type 2 diabetes.

scholarly journals Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jin Ook Chung ◽  
Seon-Young Park ◽  
Dong Hyeok Cho ◽  
Dong Jin Chung ◽  
Min Young Chung
Keyword(s):  
Type 2 Diabetes ◽  
Diabetic Retinopathy ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Growth Differentiation Factor 15 ◽  
Type 2 Dm ◽  
Differentiation Factor ◽  
Significant Difference ◽  
The Relationship

AbstractThe purpose of our study was to investigate the relationship between plasma growth differentiation factor-15 (GDF-15) concentrations and diabetic retinopathy in patients with type 2 diabetes mellitus (DM). We evaluated 235 patients with type 2 DM in a cross-sectional study. Significantly increased levels of the plasma GDF-15 were found in individuals with diabetic retinopathy versus those without. According to the degree of diabetic retinopathy, there was a significant difference in the average plasma GDF-15 levels (no diabetic retinopathy, 1114 ng/L; nonproliferative diabetic retinopathy, 1327 ng/L; proliferative diabetic retinopathy, 1445 ng/L; p for trend = 0.035) after adjustments for confounders. Logistic regression analyses indicated that plasma GDF-15 concentrations were significantly associated with diabetic retinopathy (odds ratio per 1 standard deviation increment in the log-transformed value, 1.78; 95% confidence interval, 1.05–3.03, p = 0.032). Our study showed a significant positive relationship between plasma GDF-15 concentrations and diabetic retinopathy in type 2 DM patients.

scholarly journals Prevalence of Vitamin D Deficiency among Hemodialysis Patients in Palestine: A Cross-Sectional Study

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Zaher A. Nazzal ◽  
Zakaria Hamdan ◽  
Nihal Natour ◽  
Maram Barbar ◽  
Rawan Rimawi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin D ◽  
Liver Function ◽  
Vitamin D Deficiency ◽  
Liver Function Tests ◽  
Cross Sectional Study ◽  
Hemodialysis Patients ◽  
University Hospital ◽  
Cross Sectional

Introduction. The level of vitamin D status and its relationship to kidney function and liver function among patients with and without type 2 diabetes were not studied among Palestinian hemodialysis patients before. The aim of this study was to assess the status of vitamin D in hemodialysis patients with and without type 2 diabetes and its determinants. Methods. Data were collected on 163 patients on hemodialysis therapy in the Nephrology Department at Najah National University Hospital. Information on age, sex, plasma 25 (OH)D, serum calcium, serum phosphate, parathyroid hormone, dialysis period, hypertension, diabetes, ALT, AST, albumin, alkaline phosphates, and BMI was obtained from the medical records. Data were analyzed using SPSS. Findings. The mean level of 25 (OH)D was 17.3 ± 10.5 ng/ml. Only 12.9% of subjects had 25 (OH)D levels >30 ng/ml, whereas 65% had levels between 10 and 30 ng/ml; the remaining 22.1% were severely vitamin D deficient (<10 ng/ml). Vitamin D deficiency was more prevalent among females. It was not related to PTH, calcium, kidney, or liver function tests. Conclusion. Vitamin D deficiency is highly prevalent among patients on hemodialysis with or without DM2.

scholarly journals Prevalence of thyroid dysfunction in patients with type 2 diabetes

2019 ◽  
Vol 7 (10) ◽  
pp. 3778
Author(s):  
S. A. Vaidya ◽  
B. B. Gupta ◽  
Mahak Bhandari ◽  
Simran Behl ◽  
Susmit Kosta
Keyword(s):  
Type 2 Diabetes ◽  
Thyroid Dysfunction ◽  
Cross Sectional Study ◽  
Metabolic Disturbances ◽  
Cross Sectional ◽  
Medical College ◽  
Sri Aurobindo ◽  
Significant Difference ◽  
Source Populations

 Background: Diabetes mellitus, a leading cause of death worldwide, is the most common endocrine disorder. Type 2 Diabetes (T2D) and Thyroid Dysfunction (TD) often present together and complicate each other at many levels. Recent studies find out the prevalence of TD in T2D in Malwa Region. Objective of the purpose of this study was to find out the prevalence of TD in patients with T2D.Methods: A match cross-sectional study design was conducted at Department of Medicine, Sri Aurobindo Medical College, from March 2018 to April 2019. Source populations were all patients who live in Malwa Region, Indore. A total of 150 cases were enrolled in this study, 75 cases (TD in T2D) and 75 controls were taken into study.Results: There was no significant difference in age and body mass index (BMI) between groups. The average duration of diabetes was 7.76±5.57 years and mean Hemoglobin A1c (HBA1c) was 8.17±1.66%. Only 29(38.6%) of patients had HbA1c below 7%. There was significant difference (p=0.001) in HbA1c. Prevalence of TD in T2D was significantly more in females. Out of TD in T2D patients, sub-clinical hypothyroid was present in 14.6% hypothyroidism was present in 8% patients and sub-clinical hyperthyroidism and hyperthyroidism was present in 1.3% patients.Conclusions: This study reveals about one in four people living with T2D are suffering from TD in Malwa Region. TD is common in T2D patients and can produce significant metabolic disturbances.

scholarly journals Toe-brachial index is beyond a peripheral issue in patients with type 2 diabetes

PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0253138
Author(s):  
Gisoo Darban Hosseini Amirkhiz ◽  
Mohammad Reza Babaei ◽  
Nahid Hashemi Madani ◽  
Mohammad Ebrahim Khamseh
Keyword(s):  
Type 2 Diabetes ◽  
Ankle Brachial Index ◽  
Intima Media Thickness ◽  
Carotid Intima Media Thickness ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Significant Difference ◽  
Toe Brachial Index ◽  
Peripheral Arterial

Background Atherosclerosis is the leading cause of death in patients with diabetes. We aimed to evaluate the association between ankle-brachial index (ABI) and toe-brachial index (TBI) with carotid intima-media thickness (CIMT) in patients with type 2 diabetes (T2DM). Methods This cross sectional study included 296 patients with T2DM who met the American Diabetes Association criteria for the assessment of peripheral arterial atherosclerosis. The ABI ≤ 0.9 and TBI ≤ 0.7 were considered as abnormal values. Linear and logistic regression analyses were performed to evaluate the association between TBI/ABI and CIMT. Results Right CIMT was significantly greater in the low TBI group (p = 0.03) while, left CIMT did not show a significant difference. Each 0.1-unit decrease in TBI value was independently associated with 0.017 mm increase in the right CIMT (β ± SE; -0.017 ± 0.005, p = 0.002) and with odds of the presence of increased CIMT [odds ratio and 95% confidence interval: 1.21 (1.02, 1.44)] after adjustment with all traditional risk factors. There was not any significant association between ABI and increased CIMT. Conclusions Beyond a suitable tool for the diagnosis of peripheral artery disease in patients with T2DM, TBI can be applied for prediction of subclinical carotid atherosclerosis.

Recommendation of Aspirin-Guide App and Physicians Clinical Decision of Aspirin Use to Prevent CVD Among Diabetic Patients, Is there any Differences?

2020 ◽  
pp. 107424842095897
Author(s):  
Mohammed Ali Batais ◽  
Khalid M. Almutairi ◽  
Turky H. Almigbal ◽  
Abdulaziz Alodhayani ◽  
Wadi B. Alonazi ◽  
...  
Keyword(s):  
Clinical Decision ◽  
Cross Sectional Study ◽  
Aspirin Therapy ◽  
Mobile App ◽  
University Hospital ◽  
Diabetic Patients ◽  
Patient Acceptability ◽  
Cross Sectional ◽  
Significant Difference

Objective: This study aims to identify the prevalence of aspirin use among type 2 diabetic (T2DM) patients and assess the concordance in aspirin use among these patients as prescribed by physicians and as recommended by the Aspirin-Guide app. Methods: A total of 301 T2DM patients from King Khalid University Hospital in Riyadh, Saudi Arabia participated in this cross-sectional study. Patient’s electronic medical records through eSihi system were reviewed and all data included in the free online and mobile app called Aspirin-Guide were collected in a specially designed data checklist. Result: The prevalence of aspirin use was more common in patients who were in the age group of 51 to 59 and male participants’ with T2DM. Males were nearly twice more likely to use aspirin compared to females (p = 0.001). Based on recommendations from the Aspirin-Guide app, 26% of the patients who were on aspirin (N = 51) were not eligible for aspirin therapy, while 37.7% (N = 40) of the patients eligible for aspirin therapy had not been put on aspirin by their physicians (p = 0.039). Male sex (P = 0.003), use of statins (P = 0.001), and being advised to use aspirin (P = 0.041), were significantly associated with aspirin use in T2DM patients. Conclusion: There was a significant difference in the proportion of patients currently on aspirin as prescribed by their physicians and those eligible for aspirin therapy as per the Aspirin-Guide app. The use of an app to uniformized aspirin use among eligible patients should be based on up-to-date guidelines and account for patient acceptability and willingness to commence treatment.

scholarly journals PERBANDINGAN JUMLAH TROMBOSIT PADA PASIEN DIABETES MELITUS TIPE 2 YANG MENGGUNAKAN ASPIRIN DAN TIDAK MENGGUNAKAN ASPIRIN

2013 ◽  
Vol 1 (1) ◽  
Author(s):  
Dwi P. Palimbunga ◽  
Karel Pandelaki ◽  
Arthur E. Mongan ◽  
Firginia Manoppo
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Platelet Count ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Fourfold Increase ◽  
Significant Difference ◽  
Diabetes Melitus

Abstract: Patients with type-2 diabetes mellitus are characterized by an acceleration thrombopoiesis, an increased platelet turnover and a decreased platelet survival time which affect platelet count, that cause the increasing of proportion of large and reactive platelets, and hence more thrombogenic. People with diabetes have a two- to fourfold increase in the risk of dying from the complications of cardiovascular disease. Aspirin therapy is recommended for the primary and secondary prevention of cardiovascular events in most people with diabetes. This study was an descriptive analytic method with cross sectional study design. The subjects in this study involve 112 people, 56 people treated with aspirin, and the 56 others were not who signed in endocrine metabolic department of RSUP Prof. Dr. R. D Kandou Manado. Data were taken from medical record. The Mann-Whitney test showed that there was no significant difference between the platelet count in patients with type-2 diabetes mellitus treated with aspirin and patients who were not. Conclusion: There was no significant difference between the platelet count in patients with type-2 diabetes mellitustreated with aspirin and patients who were not. Key word:Aspirin, Type-2 Diabetes Mellitus, Platelet Count  Abstrak: Pada pasien diabetes melitus tipe-2 terjadi percepatan trombopoiesis, peningkatan pergantian trombosit dan penurunan waktu hidup trombosit yang mempengaruhi jumlah trombosit, yang menyebabkan terjadinya peningkatan ukuran trombosit yang lebih besar dan reaktif, sehingga bersifat trombogenik. Risiko kematian karena komplikasi penyakit jantung meningkat dua sampai empat kali lipat. Aspirin digunakan sebagai pencegahan primer dan sekunder terhadap kejadian kardiovaskular pada pasien diabetes. Tujuan penelitian ini untuk melihat perbedaan jumlah trombosit pada pasien diabetes melitus tipe-2 yang menggunakan aspirin dan tidak menggunakan aspirin. Penelitian ini bersifat deskriptif analitik dengan rancang penelitian cross sectional. Subjek dalam penelitian ini berjumlah 112 orang, 56 orang yang menggunakan aspirin dan 56 orang lainnya tidak menggunakan aspirin yang terdaftar di Poliklinik Endokrin Metabolik RSUP Prof. Dr. R. D. Kandou Manado. Data diambil dari catatan rekam medik. Hasil penelitian menggunakan uji Mann-Whitney,menunjukkan bahwa tidak terdapat perbedaan yang signifikan antara jumlah trombosit pada pasien diabetes melitus tipe-2 yang menggunakan aspirin dan tidak menggunakan aspirin (p=0,059). Simpulan: Tidak terdapat perbedaan signifikan antara jumlah trombosit pada pasien diabetes melitus tipe 2 yang menggunakan aspirin dan tidak menggunakan aspirin. Kata Kunci: Aspirin, Diabetes Melitus Tipe-2, Jumlah Trombosit

scholarly journals Association of rs10830963 MTNR1B and rs841853 SLC2A1 Polymorphism with Obesity on Type 2 Diabetes Patients: An Overview of Melatonin Receptor and Transporter

2021 ◽  
Vol 13 (2) ◽  
pp. 155-62
Author(s):  
Yanuarita Tursinawati ◽  
Arum Kartikadewi ◽  
Ari Yuniastuti ◽  
R Susanti
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Glucose Transporter ◽  
Cross Sectional Study ◽  
Melatonin Receptor ◽  
Cross Sectional ◽  
Glucose Transporter 1 ◽  
Genotype Frequencies ◽  
Significant Difference

BACKGROUND: One of the hormones that plays a role in glucose metabolism of Type 2 Diabetes Mellitus (T2DM) is melatonin. Its genetic variation is believed to play a significant role in the pathophysiology of obese and non-obese T2DM. The role of MTNR1B (melatonin receptor coding gene) and SLC2A1 (Glucose transporter 1/GLUT 1 transporter coding gene) on the risk of obese and non-obese T2DM patients is controversial. This study aims to analyze the association between the rs10830963 MTNR1B and rs841853 SLC2A1 polymorphism to the risk of Javanese obese T2DM.METHODS: This was a cross-sectional study that involved 107 Javanese T2DM patients from primary heath care in Semarang. Furthermore, obese T2DM was defined by a body mass index (BMI) more than 25 kg/m2. The genetic variations examined were rs10830963 MTNR1B and rs841853 SLC2A1 polymorphism by PCR-RFLP methods. Blood biochemistry parameters were also examined. Allele and genotype frequencies of rs10830963 MTNR1B and rs841853 SLC2A1 polymorphisms were analyzed using the x2 test with p≤0.05 and 95% CI.RESULTS: There was a significant association between rs10830963 MTNR1B polymorphisms in obese and nonobese T2DM (p=0.044) and the CG genotype increased the risk of obese T2DM. Furthermore, the allele and genotype frequency of rs841853 SLC2A1 polymorphism in both group had no significant difference, with a p=0.756 and p=0.802, respectively. There was also no significant difference in the biochemical parameters' in both groups of the two genetic variants studied.CONCLUSION: The rs10830963 MTNR1B polymorphism is associated with the risk of obesity in Javanese T2DM patients but not for the rs841853 SLC2A1 polymorphism.KEYWORDS: polymorphism, MTNR1B, SLC2A1, obese, diabetes mellitus

scholarly journals Spirometric Indices in Type 2 Diabetes Mellitus Patients in a Nigerian Tertiary Institution

2021 ◽  
Vol 3 (3) ◽  
pp. 10-14
Author(s):  
Adekunle O. Adeoti ◽  
Taiwo H. Raimi ◽  
Joseph O. Fadare ◽  
Raphael Ibidapo
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Communicable Disease ◽  
Cross Sectional Study ◽  
Diabetic Patients ◽  
Tertiary Institution ◽  
Cross Sectional ◽  
Significant Difference

Background: Diabetes mellitus is a non-communicable disease of global health importance. It is a metabolic disorder caused by increased levels of blood glucose over a prolonged period of time. Type 2 diabetes mellitus (T2DM) is usually associated with obesity and insulin resistance. Several studies have also revealed that diabetes mellitus hampers pulmonary functions. This study was aimed at estimating the spirometric indices in type 2 diabetes mellitus patients. Methods: A cross-sectional study of T2DM patients and apparently healthy control attending the medical outpatient clinic in a tertiary institution in south western Nigeria. Results: A total of 146 participants with 73 patients with T2DM and 73 control groups. There were no significant differences in the age, body mass index, and gender distribution of the diabetics and control. However, patients with diabetes had higher SBP (133.2±20.17 mmHg vs 111.6±6.5 mmHg p<0.0001), and DBP (78.4±11.8mmHg vs 73.7±6.3 mmHg, p=0.003) when compared to the control. The mean FEV (1.98±0.5 vs 2.09±1.2, p=0.033), FVC (2.35±0.6 vs 2.53±1.3, p=0.045) and FEV/FVC ratio (83.61±7.2 vs 81.14±10.7, p=0.029) were significantly lower in diabetic patients when compared to matched controls. There was no significant difference in the PEF and FEF of both groups. Conclusion: Type 2 diabetes mellitus patients had significant decrease in their spirometric indices, hence pulmonary function should be included in the periodic comprehensive diabetic check for holistic management.

Sign in / Sign up

Export Citation Format

Share Document